Search for: "United States v. Mark" Results 4501 - 4520 of 10,391
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 May 2016, 9:29 pm by Ron Coleman
Panel on “fluid,” legacy & heritage marks – @MariaBaratta discussing Macy’s v. [read post]
26 May 2016, 4:01 am by Amy Howe
In the ABA Journal, Mark Walsh analyzes the Court’s recent decision in Luis v. [read post]
24 May 2016, 4:31 pm by Mark Patrick
On May 12, 2016, the United States Court of Appeals for the Federal Circuit addressed the patent eligibility of software in Enfish, LLC v. [read post]
23 May 2016, 12:15 am
Federal Circuit Distinguishes Enfish in New Patent Eligible Subject Matter DecisionThe patentability of computer-implemented inventions has been in doubt in the United States since the U.S. [read post]
21 May 2016, 1:01 am by rhapsodyinbooks
Nevertheless, such a philosophy did not always coincide with conservative interests, as when Burger led the court in the unanimous decision United States v. [read post]
19 May 2016, 7:33 pm by Lawrence B. Ebert
Cir. 2007) (internal quotation marks and citation omitted). [read post]
18 May 2016, 8:19 am by Dennis Crouch
 The brief supports certiorari — but only for one of the two questions presented: namely, whether a supplier can be held liable for providing ‘all or a substantial portion of the components of a patented invention’ from the United States when the supplier ships for combination abroad only a single commodity component of a multi-component invention The patent in the case involves a DNA amplification kit used for personal identification. [read post]
12 May 2016, 6:14 pm by Jason Rantanen
One need only reflect on the fact that more than 1,000 qui tam actions for false marking were filed by opportunistic plaintiffs following the 2009 Federal Circuit decision in Forest Group, Inc. v. [read post]
11 May 2016, 4:03 am
Belmora's FLANAXBased on its reading of the Supreme Court’s Lexmark decision, the lower court had dismissed Bayer’s Section 43(a) false association and false advertising claims under FRCP 12(b)(6) and entered judgment on the pleadings as to Bayer’s Section 14(3) claim, ruling that the Lanham Act does not allow an owner of a foreign mark not registered in the United States, who does not use the mark in the United States… [read post]